CF
Charles Farkas
Director

Charles Farkas insider trades: CONMED (CNMD) stock buys and sales

Director, CONMED Last trade Sep 12, 2025 29 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2015
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Charles reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 12, 2025CNMD↓ Sell$107K
May 5, 2025CNMD↓ Sell$228K
Jan 3, 2018CNMD↑ Buy10b5-1$8K
Oct 3, 2017CNMD↑ Buy10b5-1$8K
Jul 5, 2017CNMD↑ Buy10b5-1$8K
Apr 3, 2017CNMD↑ Buy$8K
Jan 3, 2017CNMD↑ Buy$14K
Oct 3, 2016CNMD↑ Buy$13K
Jul 1, 2016CNMD↑ Buy$13K
Apr 1, 2016CNMD↑ Buy$14K
Jan 4, 2016CNMD↑ Buy$14K
Oct 1, 2015CNMD↑ Buy$14K
Jul 2, 2015CNMD↑ Buy$12K
Apr 1, 2015CNMD↑ Buy10b5-1$12K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CNMD insiders

Open-market trades in the last 12 months

About Charles Farkas's insider trades

Charles Farkas is a director at CONMED (CNMD). Since Apr 1, 2015, Charles has reported 12 open-market purchases worth $139K and 2 sales worth $335K on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (14 filings), grants and awards (12 filings), shares withheld for taxes (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CNMD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.